Anafilaxia a Gadobutrol: Uma Complicação Rara ao Contraste de Ressonância Magnética

Autores

DOI:

https://doi.org/10.20344/amp.23022

Palavras-chave:

Anafilaxia, Compostos Organometálicos/efeitos adversos, Hipersensibilidade a Medicamentos/diagnóstico, Meios de Contraste/efeitos adversos, Ressonância Magnética

Resumo

n/d.

Downloads

Não há dados estatísticos.

Referências

Qu H, Li W, Wu Z, Zeng C, Yan H, Fang X, et al. Differences in hypersensitivity reactions and gadolinium deposition disease/symptoms associated with gadolinium exposure to gadolinium-based contrast agents: new insights based on global databases VigiBase, FAERS, and IQVIA-MIDAS. BMC Med. 2024;22:329. DOI: https://doi.org/10.1186/s12916-024-03537-2

Cabrera CM, Clarcast M, Palacios-Cañas A. Clinical validation of the basophil activation test in immediate hypersensitivity reactions to gadolinium-based contrast agents. Int Immunopharmacol. 2023;117:110000. DOI: https://doi.org/10.1016/j.intimp.2023.110000

Weinreb JC, Rodby RA, Yee J, Wang CL, Fine D, McDonald RJ, et al. Use of intravenous gadolinium-based contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney Foundation. Kidney Med. 2021;3:142-150. DOI: https://doi.org/10.1016/j.xkme.2020.10.001

Jutel M, Agache I, Zemelka-Wiacek M, Akdis M, Chivato T, del Giacco S, et al. Nomenclature of allergic diseases and hypersensitivity reactions: adapted to modern needs: an EAACI position paper. Allergy. 2023;78:2851-74. DOI: https://doi.org/10.1111/all.15889

Gracia Bara MT, Gallardo-Higueras A, Moreno EM, Laffond E, Muñoz Bellido FJ, Martin C, et al. Hypersensitivity to gadolinium-based contrast media. Front Allergy. 2022;3:813927. DOI: https://doi.org/10.3389/falgy.2022.813927

Downloads

Publicado

2025-07-15

Como Citar

1.
Maçães A, Nuno Silva D, Iva Santos A, Rezende I. Anafilaxia a Gadobutrol: Uma Complicação Rara ao Contraste de Ressonância Magnética. Acta Med Port [Internet]. 15 de Julho de 2025 [citado 6 de Dezembro de 2025];38(9):590-1. Disponível em: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/23022

Edição

Secção

Cartas ao Editor